CRONOS GROUP INC. (CRON) Current Ratio
- Current ratio · latest quarter: Value 16.18×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 16.18× | Current assets / current liabilities. $912.03M ÷ $56.36M ≈ 16.18× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 912.03M USD | Assets, Current |
| Current obligations | 56.36M USD | Liabilities, Current |
| Cash and equivalents | 467.02M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 36.72M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 52.70M USD | Inventory, Net |
| Payables | 17.42M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $912.03M | $56.36M | $467.02M | (m) | $36.72M | $52.70M | $17.42M | (m) | 16.18× |
| 2026-03-31 | $927.88M | $42.42M | $821.86M | (m) | $32.96M | $48.68M | $10.28M | (m) | 21.87× |
| 2025-12-31 | $944.09M | $48.19M | $791.79M | (m) | $34.10M | $46.75M | $11.64M | (m) | 19.59× |
| 2025-09-30 | $922.15M | $41.07M | $784.17M | (m) | $27.09M | $48.17M | $10.87M | (m) | 22.45× |
| 2025-06-30 | $927.15M | $37.61M | $794.42M | (m) | $26.62M | $42.14M | $12.14M | (m) | 24.65× |
| 2025-03-31 | $918.58M | $33.05M | $797.82M | (m) | $18.71M | $34.60M | $9.50M | (m) | 27.80× |
| 2024-12-31 | $936.11M | $49.70M | $858.80M | (m) | $15.46M | $33.15M | $16.97M | (m) | 18.84× |
| 2024-09-30 | $959.17M | $39.56M | $862.03M | (m) | $20.48M | $47.25M | $6.53M | (m) | 24.24× |
| 2024-06-30 | $935.28M | $33.06M | $848.19M | (m) | $16.18M | $29.18M | $7.84M | (m) | 28.29× |
| 2024-03-31 | $942.22M | $33.42M | $855.11M | (m) | $15.34M | $30.64M | $9.40M | (m) | 28.19× |
| 2023-12-31 | $933.31M | $41.40M | $669.29M | (m) | $13.98M | $30.50M | $12.13M | (m) | 22.54× |
| 2023-09-30 | $918.38M | $30.58M | $571.66M | (m) | $15.73M | $35.85M | $4.75M | (m) | 30.03× |
| 2023-06-30 | $924.77M | $27.93M | $409.43M | (m) | $12.54M | $45.19M | $9.34M | (m) | 33.12× |
| 2023-03-31 | $916.14M | $29.13M | $413.67M | (m) | $14.86M | $44.27M | $12.84M | (m) | 31.45× |
| 2022-12-31 | $960.16M | $68.12M | $764.64M | (m) | $23.11M | $37.56M | $11.16M | (m) | 14.10× |
| 2022-09-30 | $963.31M | $37.97M | $633.30M | (m) | $19.09M | $34.09M | $9.99M | (m) | 25.37× |
| 2022-06-30 | $1.03B | $39.20M | $789.54M | (m) | $19.38M | $39.84M | $12.45M | (m) | 26.18× |
| 2022-03-31 | $1.06B | $40.25M | $861.53M | (m) | $25.81M | $37.05M | $10.90M | (m) | 26.42× |
| 2021-12-31 | $1.08B | $54.37M | $886.97M | (m) | $22.07M | $32.80M | $11.11M | (m) | 19.86× |
| 2021-09-30 | $1.10B | $69.60M | $842.57M | (m) | $14.67M | $31.77M | (m) | (m) | 15.86× |
| 2021-06-30 | $1.16B | $200.60M | $895.18M | (m) | $11.30M | $35.60M | (m) | (m) | 5.79× |
| 2021-03-31 | $1.32B | $302.64M | $1.02B | (m) | $7.00M | $46.44M | (m) | (m) | 4.36× |
| 2020-12-31 | $1.37B | $206.83M | $1.08B | (m) | $8.93M | $44.00M | $19.35M | (m) | 6.63× |
| 2020-09-30 | $1.39B | $142.94M | $1.10B | (m) | $6.09M | $56.36M | (m) | (m) | 9.75× |
| 2020-06-30 | $1.40B | $235.24M | $1.11B | (m) | $3.48M | $53.22M | (m) | (m) | 5.96× |
| 2020-03-31 | $1.40B | $201.52M | $1.13B | (m) | $3.40M | $43.12M | (m) | (m) | 6.97× |
| 2019-12-31 | $1.57B | $332.89M | $1.20B | (m) | $4.64M | $38.04M | $9.19M | (m) | 4.73× |
| 2018-12-31 | $39.94M | $33.27M | $23.93M | (m) | $3.05M | $7.39M | $1.17M | (m) | 1.20× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |